Category Archives: Opioid Treatment

Federal Rules For Methadone Access Are Changing

The synthetic opioid, fentanyl, has led to an increase in overdose deaths in recent years. As many as 112,000 in the last year according to NPR. As a result, some physicians are pushing to make methadone more available to those who need it.

The Biden administration has created new federal rules for methadone treatment designed to widen access for more patients. In particular, the requirement of one year of active opioid addiction is being reduced to just 6 months of opioid addiction in order to become eligible to receive methadone.

There are about 2000 federally-approved opioid treatment programs (OTP) in the United States. Many thousands of patients are receiving life saving services from these clinics. Since COVID, many OTP clinics have made take home medication more accessible to those in early phases of treatment.

With illegal opiates still flooding the country, increasing access to opioid treatment and medication is easily justified. The question remains as to how local law enforcement can ultimately stem the flow of drugs into the community, as well as how youth can be educated to avoid risking first drug use.

How Bad Is Opioid Withdrawal

There is an informative video by Sarah Wakeman on the physical and psychological perils of severe opioid withdrawal. Sarah is a Medical Director at Mass General Brigham. They are an integrated health care system that conduct medical research, teaching, and patient care.

In the video, Sarah explains how opioid withdrawal can become so severe with diarrhea and vomiting that individuals can die from extensive dehydration. As physicial dependency progresses, the brain becomes increasingly imbalanced and unable to function without the presence of opioids.

When opioid withdrawal commences (usually 8-12 hours after last use), it becomes increasingly unbearable as the body is flushed with stress hormones. The withdrawal discomfort builds in intensity over days, and can last up to a week or more. For many, this withdrawal process feels akin to a severe case of the flu, but then potentially reaches levels of sickness even far beyond that.

In the video, Sarah goes on to discuss the benefits of methadone and buprenorphine in reducing severe withdrawal symptoms and in helping patients to ultimately not die from overdose. She also illuminates on how rational decision-making is so extremely difficult when struggling against the intense pain of opioid withdrawal.

Please check this video out, and share it with anyone you believe can benefit from its message.

Expanding Access to Methadone

Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.

Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.

In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.

Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.

Buprenorphine After Overdose Facilitates Treatment

Several articles recently addressed a study which found that providing buprenorphine after an overdose significantly increased the likelihood of individuals accessing opioid use disorder (OUD) treatment.

The current protocol for paramedics and emergency departments in treating opioid overdose is to administer naloxone in order to reverse the effects of overdose. A recently published study showed that also providing buprenorphine immediately afterward reduced withdrawal discomfort and increased outpatient addiction follow-up care.

A separate article referenced data showing a nearly six-fold increase in patients accessing outpatient addiction treatment within 30 days of the overdose event.

These are highly encouraging finds which demonstrate the far-reaching effectiveness of medication-assistance in the treatment of opioid addiction. Saving a life through overdose reversal is obviously a critical benefit, but increasing motivation for follow-up treatment is a huge step in helping addicted individuals plug into a long-term solution.

Structured treatment which utilizes medication-assistance provides so much to those aspiring to face their addiction challenges. Naloxone, buprenorphine, and methadone have saved countless lives, and these medications have provided an unrivaled opportunity for those in opioid addiction to plot a new path in life.

Longer Duration Opioid Treatment Improves Outcomes

A new study by the School of Medicine and Public Health at the University of Wisconsin found that a patient’s length of treatment is directly tied to lower risk of overdose.

In particular, treating opioid addiction with medication for at least 60 days generated a 61% reduction in the incidence of overdose.

Numerous other studies over the last two decades have shown that positive outcomes are tied to longer duration in outpatient addiction treatment. Not only does greater length of time in treatment allow for physical stabilization with methadone or buprenorphine, but it provides each patient with time to develop improved coping skills and relapse prevention capability.

Higher levels of functioning are able to be achieved, such as gainful employment and improved parenting, when a patient is able to remain in addiction treatment for longer periods of time.

Marguerite Burns, who led the Wisconsin study, found that recovery success and overdose prevention are enhanced the longer that patients take medication over a 12 month period. Medication-assistance plays a key role in helping opioid addicted patients find long lasting recovery.

Impressively, the study was based on treatment outcomes recorded for 293,160 Medicaid patients diagnosed with opioid use disorder.